Recent Advances in Development of Small Molecules to Fight Cancer—Volume II
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 104
Special Issue Editors
Interests: small-molecule drug design; anti-cancer drugs; organic synthesis; medicinal chemistry; cancer; enzymatic assays; structure–activity relationship (SAR)
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; drug discovery; chemical synthesis; PROTAC; anticancer agents; cancer metabolism; endocannabinoid system
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is the second leading cause of death worldwide these days. Despite many efforts in recent years being made to fight this enemy, various types of cancer possess a poor prognosis, and their treatment is ineffective and/or extremely expensive. Thus, developing new and more effective drugs for cancer treatment still remains an urgent and unmet medical need.
In the second volume of this Special Issue of Molecules, we will focus on the recent advancements and challenges in the development of small molecules used to tackle cancer. This will include the identification, biological, and pharmacological evaluation of novel anticancer agents, and also the identification of new biological targets and new therapeutic approaches concerning cancer drug design. Please contribute to this Special Issue with original research articles, short communications, and review articles.
Dr. Giulia Bononi
Prof. Dr. Carlotta Granchi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry
- drug discovery
- anti-cancer drugs
- natural products
- synthetic compounds
- synthesis
- biological evaluation
- cancer treatment
